ArabFinance:  Kahira Pharmaceuticals and Chemical Industries Company (CPCI) ordinary general meeting (OGM) approved distributing annual dividends of EGP 4 per share for the fiscal year (FY) 2019/2020, according to the company’s September 27th statement filed to the Egyptian Exchange.

The OGM approved on, on September 26th,  the financial results and dividends for FY 2019/2020.

The company reported a net profit of EGP 109.140  million in FY 2019/2020, a 28% rise from EGP 85.170  million posted a prior-year period.

In late May, the company's extraordinary general meeting approved a capital increase from EGP 19,475,000 to EGP 149,343,750.

Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.